CD8A and neoplasm: Consistent with this, the RT-triggered anti-tumor response in intracranial LLC, as measured by the number and proliferation of CD8+ T cells, was stronger in the VEGF-C overexpression group than in the vector group (Supplementary information, Fig. S11d–i).